None
Quote | Charles River Laboratories International Inc. (NYSE:CRL)
Last: | $233.47 |
---|---|
Change Percent: | -1.11% |
Open: | $224.27 |
Close: | $233.47 |
High: | $233.915 |
Low: | $224.27 |
Volume: | 646,107 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Charles River Laboratories International Inc. (NYSE:CRL)
Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries into novel therapeutics Under the agreement, Charles River will make an equity investment in Aut...
2024-07-19 02:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Renewed leadership by ...
Message Board Posts | Charles River Laboratories International Inc. (NYSE:CRL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CRL News Article - Trading Charles River $CRL With Integrated Risk Controls | whytestocks | investorshangout | 04/24/2023 7:40:49 PM |
whytestocks: $CRL News Article - INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investi | whytestocks | investorshangout | 02/23/2023 8:25:48 PM |
whytestocks: $CRL News Article - Why Charles River Laboratories Stock Is Jumping Today | whytestocks | investorshangout | 11/02/2022 4:30:52 PM |
whytestocks: $CRL News Article - Charles River Laboratories Announces Third-Quarter 2022 Results | whytestocks | investorshangout | 11/02/2022 3:25:50 PM |
whytestocks: $CRL News Article - Charles River Laboratories Publishes 2021 Corporate Citizenship Rep | whytestocks | investorshangout | 04/07/2022 4:30:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries into novel therapeutics Under the agreement, Charles River will make an equity investment in Aut...
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 7 th , at 9:00 a.m. ET. Investors wi...
Critical starting material manufacture for therapeutic targeting high unmet need ophthalmology indication Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde today announced a contract development and manufacturing organization (CDMO) agreement to produce Good...